Endotheliopathy in acute COVID-19 and long COVID

AG Vassiliou, CS Vrettou, C Keskinidou… - International Journal of …, 2023 - mdpi.com
The pulmonary endothelium is a highly regulated organ that performs a wide range of
functions under physiological and pathological conditions. Since endothelial dysfunction …

[HTML][HTML] Rethinking endothelial dysfunction as a crucial target in fighting heart failure

C Premer, AJ Kanelidis, JM Hare… - Mayo Clinic Proceedings …, 2019 - Elsevier
Endothelial dysfunction is characterized by nitric oxide dysregulation and an altered redox
state. Oxidative stress and inflammatory markers prevail, thus promoting atherogenesis and …

Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)

M Haffke, H Freitag, G Rudolf, M Seifert… - Journal of Translational …, 2022 - Springer
Background Fatigue, exertion intolerance and post-exertional malaise are among the most
frequent symptoms of Post-COVID Syndrome (PCS), with a subset of patients fulfilling …

Treatment of angina: where are we?

C Balla, R Pavasini, R Ferrari - Cardiology, 2018 - karger.com
Ischaemic heart disease is a major cause of death and disability worldwide, while angina
represents its most common symptom. It is estimated that approximately 9 million patients in …

Ivabradine in chronic stable angina: effects by and beyond heart rate reduction

PG Camici, S Gloekler, BI Levy, E Skalidis… - International journal of …, 2016 - Elsevier
Heart rate plays a major role in myocardial ischemia. A high heart rate increases myocardial
performance and oxygen demand and reduces diastolic time. Ivabradine reduces heart rate …

Rosuvastatin protects against oxidized low‑density lipoprotein‑induced endothelial cell injury of atherosclerosis in vitro

J Geng, H Xu, X Yu, G Xu, H Cao… - Molecular Medicine …, 2019 - spandidos-publications.com
Atherosclerosis‑induced cardiovascular diseases (CVDs) are accompanied by substantial
morbidity and mortality. The loss and injury of endothelial cells is the primary cause of …

Effects of ivabradine on endothelial function, aortic properties and ventricular‐arterial coupling in chronic systolic heart failure patients

I Bonadei, E Sciatti, E Vizzardi… - Cardiovascular …, 2018 - Wiley Online Library
Aim Heart rate (HR) is an important prognostic factor in patients affected by chronic heart
failure (CHF); ivabradine has been demonstrated to significantly reduce nonfatal myocardial …

HIV and race are independently associated with endothelial dysfunction

C Mouchati, JC Durieux, SN Zisis, GA McComsey - AIDS, 2023 - journals.lww.com
Objective: Evaluating the vascular function in HIV-infected compared with HIV uninfected
with assessment of body composition, inflammation, and gut integrity markers. Design: A …

The role of ivabradine in the management of angina pectoris

A Giavarini, R de Silva - Cardiovascular Drugs and Therapy, 2016 - Springer
Abstract Stable angina pectoris affects 2–4% of the population in Western countries and
entails an annual risk of death and nonfatal myocardial infarction of 1–2% and 3 …

Effects of Ivabradine on Myocardial Perfusion in Chronic Angina: A Prospective, Preliminary, Open-Label, Single-Arm Study

OR França Neto, MM Fernandes-Silva, RJ Cerci… - Cardiology and …, 2024 - Springer
Introduction Ivabradine reduces heart rate (HR), episodes of angina, and nitrate
consumption, and increases exercise capacity in patients with chronic angina (CA). In this …